Frederic joined Akoya Biosciences in April 2021 to serve as the Chief Operating Officer. He brings over 25 years of experience in launching and managing global businesses in the life sciences and healthcare industries. Most recently, he served as Chief Operating Officer at the Parker Institute for Cancer Immunotherapy (PICI). Prior to PICI, he served as COO of Genomic Health (now part of Exact Sciences) and held senior leadership positions at Life Technologies (now part of Thermo Fisher Scientific) and GE Healthcare. Frederic is named on 23 U.S. patents and received a PhD in acoustics from Pennsylvania State University, a Master’s degree from the University of Southampton, UK, and an engineering degree from the University of Technology of Compiegne, France.